Examkin

Question

Difficulty: HardDiagnostic Workup and Test Sequencing

A gastroenterology consultation is requested for a female in her mid-forties suffering from relentless burning abdominal discomfort and persistent loose, watery stools for the past eight months. The abdominal distress frequently awakens her from sleep. Outpatient medical records indicate that a recent upper endoscopy revealed markedly thickened gastric folds alongside multiple mucosal ulcerations extending deep into the postbulbar duodenum. Biopsy specimens from the gastric antrum showed no evidence of Helicobacter pylori organisms. Her current medications include high-dose esomeprazole, which was initiated two weeks ago following the endoscopy but has provided minimal symptomatic relief. To properly evaluate her condition, the proton pump inhibitor is discontinued and temporarily replaced with an H2-receptor antagonist, which is subsequently stopped 4848 hours prior to laboratory testing. A fasting serum gastrin concentration is then measured at 620620 pg/mL (normal: <100< 100 pg/mL) alongside a simultaneously recorded basal gastric pH of 1.41.4. Which of the following is the most appropriate next step in the diagnostic workup?

  1. Secretin stimulation testAnswer
  2. B
    Somatostatin receptor scintigraphy
  3. C
    Endoscopic ultrasound of the pancreas
  4. D
    Measurement of fasting serum calcium and intact parathyroid hormone
  5. E
    Measurement of serum vasoactive intestinal peptide

Answer

The secretin stimulation test is required to biochemically confirm the diagnosis of Zollinger-Ellison syndrome when fasting serum gastrin levels are moderately elevated rather than definitively diagnostic.
In patients with clinical features of Zollinger-Ellison syndrome (ZES), the initial diagnostic step is measuring fasting serum gastrin alongside gastric pH. A gastrin level greater than 1,000 pg/mL in the presence of acidic gastric pH (<2.0< 2.0) is definitively diagnostic, allowing clinicians to proceed directly to tumor localization. However, if the gastrin level is elevated but less than 1,000 pg/mL (as seen in this patient with a level of 620 pg/mL), the value is considered equivocal. In this scenario, clinical guidelines mandate a secretin stimulation test as the next required step to establish the biochemical diagnosis. During this test, exogenous secretin is administered; while it normally suppresses gastrin release from physiologic gastric G cells, it paradoxically stimulates a dramatic rise in gastrin (typically >120> 120 pg/mL over baseline) from gastrinoma cells. Only after this paradoxical rise confirms the diagnosis should imaging modalities be ordered.

Step-by-Step Solution

1
Interpret the clinical presentation and endoscopic findings.
Postbulbar ulcers, prominent gastric folds, and chronic watery diarrhea are highly suspicious for a gastrinoma (Zollinger-Ellison syndrome).
Gastrin hypersecretion leads to excessive gastric acid production, causing atypical or refractory ulcers and acid-mediated inactivation of pancreatic enzymes, which results in diarrhea.
2
Evaluate the initial laboratory values.
The fasting serum gastrin is 620 pg/mL, and the gastric pH is 1.4.
A pH of less than 2.0 confirms true acid hypersecretion, ruling out secondary hypergastrinemia caused by achlorhydria. The gastrin level is abnormal but falls in the intermediate/equivocal range (110 to 1,000 pg/mL).
3
Determine the algorithmic sequencing step based on the equivocal laboratory result.
A provocative test must be performed to differentiate a gastrinoma from other causes of hypergastrinemia before proceeding to any tumor localization imaging.
Exogenous secretin normally inhibits gastrin release from physiologic G cells, but paradoxically stimulates gastrin release from gastrinoma cells, firmly establishing the biochemical diagnosis.

Key Concept

Diagnostic sequencing for Zollinger-Ellison syndrome strictly requires definitive biochemical confirmation (using a secretin stimulation test for equivocal gastrin levels) prior to performing any localizing imaging studies.
Rate this question

Topics

Diagnostic Workup and Test Sequencing

More questions from this topic